These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease. Burrin DG; Ng K; Stoll B; Sáenz De Pipaón M Adv Nutr; 2014 Jan; 5(1):82-91. PubMed ID: 24425726 [TBL] [Abstract][Full Text] [Related]
11. Low-Dose Parenteral Soybean Oil for the Prevention of Parenteral Nutrition-Associated Liver Disease in Neonates With Gastrointestinal Disorders. Calkins KL; Havranek T; Kelley-Quon LI; Cerny L; Flores M; Grogan T; Shew SB JPEN J Parenter Enteral Nutr; 2017 Mar; 41(3):404-411. PubMed ID: 26024828 [TBL] [Abstract][Full Text] [Related]
12. Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions. Guthrie G; Kulkarni M; Vlaardingerbroek H; Stoll B; Ng K; Martin C; Belmont J; Hadsell D; Heird W; Newgard CB; Olutoye O; van Goudoever J; Lauridsen C; He X; Schuchman EH; Burrin D J Lipid Res; 2016 Sep; 57(9):1696-711. PubMed ID: 27474222 [TBL] [Abstract][Full Text] [Related]
13. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial. Savini S; D'Ascenzo R; Biagetti C; Serpentini G; Pompilio A; Bartoli A; Cogo PE; Carnielli VP Am J Clin Nutr; 2013 Aug; 98(2):312-8. PubMed ID: 23761482 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease. Pastor-Clerigues A; Marti-Bonmati E; Milara J; Almudever P; Cortijo J PLoS One; 2014; 9(12):e115404. PubMed ID: 25502575 [TBL] [Abstract][Full Text] [Related]
15. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Fallon EM; Le HD; Puder M Curr Opin Organ Transplant; 2010 Jun; 15(3):334-40. PubMed ID: 20503524 [TBL] [Abstract][Full Text] [Related]
16. Fish oil-based injectable lipid emulsions containing medium-chain triglycerides or added α-tocopherol offer anti-inflammatory benefits in a murine model of parenteral nutrition-induced liver injury. Baker MA; Cho BS; Anez-Bustillos L; Dao DT; Pan A; O'Loughlin AA; Lans ZM; Mitchell PD; Nosé V; Gura KM; Puder M; Fell GL Am J Clin Nutr; 2019 Apr; 109(4):1038-1050. PubMed ID: 30882140 [TBL] [Abstract][Full Text] [Related]
17. Mixed Lipid, Fish Oil, and Soybean Oil Parenteral Lipids Impact Cholestasis, Hepatic Phytosterol, and Lipid Composition. Isaac DM; Alzaben AS; Mazurak VC; Yap J; Wizzard PR; Nation PN; Zhao YY; Curtis JM; Sergi C; Wales PW; Mager DR; Turner JM J Pediatr Gastroenterol Nutr; 2019 Jun; 68(6):861-867. PubMed ID: 30889135 [TBL] [Abstract][Full Text] [Related]
18. Liver Disease, Systemic Inflammation, and Growth Using a Mixed Parenteral Lipid Emulsion, Containing Soybean Oil, Fish Oil, and Medium Chain Triglycerides, Compared With Soybean Oil in Parenteral Nutrition-Fed Neonatal Piglets. Turner JM; Josephson J; Field CJ; Wizzard PR; Ball RO; Pencharz PB; Wales PW JPEN J Parenter Enteral Nutr; 2016 Sep; 40(7):973-81. PubMed ID: 25837680 [TBL] [Abstract][Full Text] [Related]
19. Impact of parenteral fat composition on cholestasis in preterm infants. Teng J; Arnell H; Bohlin K; Nemeth A; Fischler B J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):702-7. PubMed ID: 25633496 [TBL] [Abstract][Full Text] [Related]